| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 05/22/2003 | US20030096806 For use as pesicides, herbicides; crop protection |
| 05/21/2003 | EP1312608A2 Discodermolide analogues and their pharmaceutical use |
| 05/21/2003 | EP1311475A1 Novel aminocyclohexane derivatives |
| 05/21/2003 | EP1311473A2 Novel compounds inhibiting factor xa activity |
| 05/21/2003 | EP1311253A2 Use of vitamin d derivatives as bone resorption inhibitors |
| 05/21/2003 | EP1268462A4 A process for producing simvastatin |
| 05/21/2003 | EP1265884A4 A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities |
| 05/21/2003 | EP1263979A4 Method of purifying a fermentation broth |
| 05/21/2003 | EP1091970B1 Method for preparing aloin by extraction |
| 05/21/2003 | EP1027316B1 Synthesis of aryl ethers, methods and reagents related thereto |
| 05/21/2003 | CN1419532A Novel fatty acid analogous |
| 05/20/2003 | US6566538 Substituted oxygen alicyclic compounds, including methods for synthesis thereof |
| 05/20/2003 | US6566373 For therapy of osteoporosis, periodontitis, and arthritis |
| 05/20/2003 | US6566120 Contacting compactin with an agent derived from Actinomadura under conditions in which agent converts compactin to pravastatin; anticholesterol agent |
| 05/15/2003 | WO2003040138A1 Dimeric compounds and their use as anti-viral agents |
| 05/15/2003 | WO2003040137A1 Dimeric compounds and their use as anti-viral agents |
| 05/15/2003 | WO2003040136A1 Dimeric compounds and their use as anti-viral agents |
| 05/15/2003 | WO2003040135A1 Dimeric compounds and their use as anti-viral agents |
| 05/15/2003 | WO2003040104A1 Dimeric pharmaceutical compounds and their use |
| 05/15/2003 | WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/15/2003 | CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/14/2003 | EP1309583A2 Process for preparing discodermolide and analogues thereof |
| 05/14/2003 | EP1309565A1 Heterocyclic mutilin esters and their use as antibacterials |
| 05/14/2003 | EP1309531A1 Derivatives of 4-(trifluoromethyl)-phenol and 4-(trifluoromethylphenyl)-2-(tetrahydropyranyl) ether and method for producing the same |
| 05/14/2003 | EP1139760B1 Cyclohexenone oxime ether / (glyphosates / gluphosinates) suspension concentrates |
| 05/14/2003 | CN1418207A Agents correcting gene expression regulatory error |
| 05/14/2003 | CN1418193A heterocyclic side chain containing metalloprotease inbibitors |
| 05/13/2003 | US6562984 Mixing with surfactants and detergent; purification by ion exchanging |
| 05/08/2003 | WO2003037906A1 Antimicrobial use of anhydrofructose derivatives |
| 05/08/2003 | WO2003037867A1 Processes for the manufacturing of 3-hydroxy-n,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide |
| 05/08/2003 | WO2003037353A1 Improvements relating to prostaglandins and their analogues |
| 05/08/2003 | US20030088039 Composition |
| 05/08/2003 | US20030087934 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
| 05/08/2003 | US20030087890 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide |
| 05/07/2003 | EP1307579A2 Bio-intermediates for use in the chemical synthesis of polyketides |
| 05/07/2003 | EP1307437A1 Method for producing 3,4-dihydro-2h-pyran |
| 05/06/2003 | US6559337 Containing C17-23 divalent hydrocarbon group containing a bridged cyclic hydrocarbon group, as well as an acid decompsable group |
| 05/06/2003 | US6559176 A method for regulating the activity of an autoinducer-2 receptor comprising contacting an autoinducer-2 receptor with an AI-2 agonist or antagonist compound. |
| 05/06/2003 | US6558942 Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold |
| 05/02/2003 | EP1305301A1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 05/02/2003 | EP1070058B1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 05/02/2003 | EP0934939B1 Neuraminic acid compounds |
| 05/01/2003 | US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives |
| 05/01/2003 | US20030083359 Treating pain, urinary incontinence and bladder overactivity; P2X receptors are cation-permeable ion channels |
| 05/01/2003 | US20030083333 1,4-Disubstituted benzo-fused compounds |
| 05/01/2003 | US20030080320 Combining a tertiary amide with a pentavalent phosphorous halide in a solvent to form an alpha - haloiminium salt and converting the alpha -haloiminium salt to the alpha -haloenamine with a base |
| 04/29/2003 | US6555690 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 04/29/2003 | US6555567 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides |
| 04/24/2003 | WO2003032995A1 Rosuvastatin in pre demented states |
| 04/24/2003 | WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032905A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
| 04/24/2003 | WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 04/24/2003 | US20030078440 O- or S- substituted tetrahydronaphthalene derivatives useful as regulators of cell proliferation and differentiation, useful for treating skin-related diseases |
| 04/24/2003 | US20030078428 Phenylamino benzhydroxamic acid derivatives inhibit certain dual specificity kinase enzymes involved in proliferative diseases such as cancer, psoriasis and restenosis; inhibit the phosphorylation of MAP kinase by MEK |
| 04/24/2003 | US20030078250 Diphenyl urea compounds for treating a chemokine mediated disease; interleukin-8 (il-8) |
| 04/24/2003 | US20030078239 Ketone compounds and compositions for cholesterol management and related uses |
| 04/24/2003 | US20030077760 Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold |
| 04/24/2003 | US20030077707 Adjusting transferase domain in modular polyketide synthase; obtain nucleotide sequences, adjust sequences, express sequences, monitor activity of synthase |
| 04/24/2003 | CA2684419A1 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity |
| 04/24/2003 | CA2463597A1 Rosuvastatin in pre demented states |
| 04/23/2003 | EP1303505A1 Phenyl-substituted 5,6-dihydropyrone derivatives for use as pesticides and herbicides |
| 04/23/2003 | EP1303482A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 04/23/2003 | EP1303268A1 Highly purified simvastatin compositions |
| 04/23/2003 | EP1051387B1 Anticancer platinum (iv) complexes for oral administration |
| 04/23/2003 | EP1007032B1 4-cyano-4-deformylsordaricin derivatives |
| 04/23/2003 | EP0993442B1 Hydrazine derivatives |
| 04/23/2003 | EP0915846B1 2- and 2,5-substituted phenylketoenols |
| 04/23/2003 | EP0885391B1 Method of detection of influenza virus and compounds for use therein |
| 04/22/2003 | US6552204 Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one |
| 04/22/2003 | US6552176 Salt forms of 6-n-butylamino-6-deoxy-α-L-sorbofuranose |
| 04/22/2003 | US6552073 Compounds and methods of treating cell proliferative diseases |
| 04/17/2003 | WO2003006454A3 Heterocyclic carboxamides and their use as fungicides |
| 04/17/2003 | US20030073851 Arylphenyl-substituted cyclic ketoenols |
| 04/17/2003 | US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 04/17/2003 | US20030073838 3-alkyl-3-phenyl-piperidines |
| 04/17/2003 | US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 04/16/2003 | EP1302469A1 Process for producing hydroxylactone |
| 04/16/2003 | EP1301458A1 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis |
| 04/16/2003 | EP0971913B1 Process for the production of semi synthetic statins via novel intermediates |
| 04/16/2003 | CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 04/15/2003 | WO2002036538A1 Process for producing esterificated condensate |
| 04/15/2003 | US6548476 Dimeric inhibitors of influenza neuraminidase |
| 04/15/2003 | CA2426000A1 Method for preparing ester condensate |
| 04/10/2003 | WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | WO2003028662A2 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
| 04/10/2003 | US20030068677 Recombinant production of novel polyketides |
| 04/10/2003 | CA2462661A1 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
| 04/10/2003 | CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/09/2003 | EP1299372A1 Pyrones as inhibitors of cyclooxygenase-2 |
| 04/09/2003 | EP1299340A2 Process for the isolation of lovastatin |
| 04/09/2003 | EP1021457B1 Method for the site specific synthesis of novel 3-hydroxypyridin-4(1h)-ones derivatives from aminoitols, products obtained by this method and their applications |
| 04/09/2003 | EP0848612B1 Use of calendula glycosides for the treatment of psoriasis |
| 04/09/2003 | EP0758327B1 Pyranone compounds useful to treat retroviral infections |
| 04/09/2003 | CN1409707A Processes for producing tetrahydropyranyl-4 sulfonate and 4-amino tetrapyran compound |
| 04/09/2003 | CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds |
| 04/08/2003 | US6545165 Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one |
| 04/08/2003 | US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders |
| 04/08/2003 | US6544951 Antiinflammatory agents; autoimmune diseases, nervous system degradation |
| 04/03/2003 | US20030065023 Anticancer agents, viricides, psychological disorders |
| 04/03/2003 | US20030064976 Reacting ammonium formate, aldehyde and alkyl isocyanate |